Dr. John Magnani GlycoMimetics, USA

John Magnani is an expert in glycobiology having identified and characterized many carbohydrate tumor antigens, such as CA19-9, and developed fundamental technology for the identification of functional carbohydrate epitopes. Prior to co-founding GlycoMimetics, Dr. Magnani founded and led GlycoTech Corporation as its President and CEO. Previously, he helped co-found the... read moreU.S. subsidiary of BioCarb and became its Vice President of Research. Dr. Magnani received his PhD from Princeton University and then joined the Laboratory of Biological Pharmacology of the National Institute of Arthritis, Diabetes and Digestive and Kidney Diseases, (NIADDK) of the National Institutes of Health. He remained at the NIH for ten years, finally serving as a tenured Research Chemist.